Glenmark Pharmaceuticals – Manufacturer of Medicines

Glenmark

Country: India

Glenmark Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1977 by Gracias Saldanha and headquartered in Mumbai. Its shares are listed on India's NSE and BSE stock exchanges.

Glenmark makes generic and branded medicines and runs its own research. Its main areas are dermatology, respiratory care and oncology, and its portfolio also covers diabetes and cardiovascular disease. One of its own products is Ryaltris (olopatadine and mometasone), a nasal spray for allergic rhinitis approved by the US FDA.

Innovative oncology research is concentrated in its subsidiary Ichnos Glenmark Innovation, formed in 2024. In 2025 Glenmark signed a licensing agreement with AbbVie for ISB 2001, an investigational multiple myeloma drug, with an upfront payment of 700 million US dollars.

Glenmark has plants in India, the US, Argentina and the Czech Republic. In 2024 it sold a 75% stake in its active ingredient maker, Glenmark Life Sciences, to Nirma. Glenmark medicines are sold in more than 80 countries.

Unifarm carries Glenmark medicines: Nindanib (nintedanib), Evermil (everolimus), Abirapro (abiraterone) and Aprezo (apremilast).

Official manufacturer website
Glenmark

List of medicines by manufacturer Glenmark

-12%
Nindanib
View
Glenmark
150 mg 10 capsules
1670₴ 1890₴
-13%
Evermil
View
Glenmark
10 mg 10 tablets
4670₴ 5364₴
-26%
Aprezo
View
Glenmark
30 mg 60 tablets
2637₴ 3576₴
-13%
Abirapro
View
Glenmark
250 mg 120 tablets
5811₴ 6705₴
✅ All products loaded (4)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00